Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
BIPHENTIN ELVIUM LIFE SCIENCES Actual shortage 30MG Updated Report 2023-01-30 180941
GD-DICLOFENAC/MISOPROSTOL 50 GENMED A DIVISION OF PFIZER CANADA ULC Actual shortage 200MCG 50MG Updated Report 2023-01-30 180226
IDARUBICIN PFIZER CANADA ULC Anticipated shortage 1MG Updated Report 2023-01-30 176929
YAZ PLUS BAYER INC Actual shortage 0.451MG 0.451MG 0.02MG 3.00MG Updated Report 2023-01-30 172253
GENTAMICIN(E) BAXTER CORPORATION Actual shortage 1.6MG Updated Report 2023-01-30 179918
JANUVIA MERCK CANADA INC Anticipated shortage 100MG Updated Report 2023-01-30 182687
APO-VALPROIC ACID ORAL SOLUTION APOTEX INC Anticipated shortage 250MG Updated Report 2023-01-30 182684
0.9% SODIUM CHLORIDE IRRIGATION, USP BAXTER CORPORATION Actual shortage 900MG Updated Report 2023-01-30 181393
SORBITOL MANNITOL IRRIGATION ICU MEDICAL CANADA INC Actual shortage 5.4MG 27MG Updated Report 2023-01-30 180329
SODIUM CHLORIDE INJECTION USP ICU MEDICAL CANADA INC Anticipated shortage 9MG New Report 2023-01-30 182677

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
RUZURGI MEDUNIK CANADA Reversed 10MG Updated Report 2023-01-27 156611
FORADIL DRY POWDER CAPSULES FOR INHALATION NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 12MCG Updated Report 2023-01-25 172087
ONIVYDE SERVIER CANADA INC Reversed 4.3MG Updated Report 2023-01-25 164803
IBAVYR PENDOPHARM DIVISION OF PHARMASCIENCE INC Discontinued 200MG Updated Report 2023-01-20 182060
IBAVYR PENDOPHARM DIVISION OF PHARMASCIENCE INC Discontinued 400MG Updated Report 2023-01-20 182029